RSS chief Mohan Bhagwat said the present global and national situation is worrying, but India has faced similar challenges in ...

Ministries and governance institutions in Accra have recorded a large number of workers at post attending to their official duties, a marked departure from the norm when workers trickled in after the ...

Cuban Ambassador to India, Juan Carlos Marsan Aguilera, praised India’s efforts to resolve international conflicts through ...

After 104 years in Fulton, Ill., Unity Christian Schools opens a new Clinton campus, giving students more space and room to ...

The Federal Government has reaffirmed Nigeria’s unwavering commitment to advancing health security across West Africa, ...

The last time I wrote about Allogene Therapeutics, Inc. (ALLO) it was in a Seeking Alpha article entitled "Allogene: Two End Of 2024 Data Readouts With Improved Allogeneic CAR-T Products." I noted the ...

Less than half of the healthcare providers correctly identified refractory chronic cough (RCC) as a cough lasting more than 8 weeks and not responding to treatment, based on survey data from more than ...

Pembrolizumab plus axitinib shows superior long-term efficacy over sunitinib in advanced RCC, with improved overall and progression-free survival rates. Biomarker analysis suggests a higher ...

Former Valley Center High School and San Diego State quarterback Kevin Craft has been named head football coach at Riverside City College, taking over for his father Tom, who retired at the end of ...

RCC is a short-term, exchange-listed baby bond from Ready Capital, maturing in February 2026, offering an 8.5% yield to maturity. The bond's very short duration minimizes market risk, making solvency ...

Partial nephrectomy was associated with the highest survival rate among patients with localized RCC aged 75 years and older compared with radical nephrectomy, ablation, and surveillance. Despite its ...

Dr. Laurence Albiges discusses triplet therapies, highlighting which patients with RCC may garner the most benefit with this treatment intensification. The phase 3 COSMIC-313 trial evaluated Cabometyx ...